about
The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes.Sexual abuse and lifetime diagnosis of psychiatric disorders: systematic review and meta-analysis.Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states.Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic study.A new interaction between SLC6A4 variation and child abuse is associated with resting heart rate.Serotonin transporter gene promotor polymorphism (5-HTTLPR) associations with number of psychotropic medication trials in a tertiary care outpatient psychiatric consultation practice.Investigation of serotonin transporter gene (SLC6A4) by child abuse history interaction with body mass index and diabetes mellitus of White female depressed psychiatric inpatients.State dependent gene-environment interaction: serotonin transporter gene-child abuse interaction associated with suicide attempt history among depressed psychiatric inpatients.HTR2A gene-child abuse interaction and association with a history of suicide attempt among Caucasian depressed psychiatric inpatients."Diminished" association between the serotonin transporter linked polymorphism (5HTTLPR) and body mass index in a large psychiatric sample.Does 5HTTLPR long allele prevent hospitalization? Test of Hardy-Weinberg equilibrium.CYP2C19 variation, not citalopram dose nor serum level, is associated with QTc prolongation.New developments in the genetics of bipolar disorder.The integrated model of serotonin transporter gene variation (5HTTLPR) and the glial cell transporter in stress vulnerability and depression.Letter to the Editor: Posttraumatic stress disorder has genetic overlap with cardiometabolic traits.Pharmacogenomic testing in a tertiary care outpatient psychosomatic medicine practice.Relationship between FKBP5 polymorphisms and depression symptoms among kidney transplant recipients.Post-pump chorea--choreiform movements developing after pulmonary thromboendarterectomy for chronic pulmonary hypertension presenting as "functional" movement disorder.GWAS and systems biology analysis of depressive symptoms among smokers from the COPDGene cohortThe point-of-care EEG for delirium detection in the emergency departmentPharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failureGenome-wide DNA methylation comparison between live human brain and peripheral tissues within individualsRelationship of Genetic Variation in the Serotonin Transporter Gene (SLC6A4) and Congenital and Acquired Cardiovascular DiseasesContinuous un-SERT-ainty of 5-HTTLPRIntegrated Inpatient Medical and Psychiatric Care: Experiences of 5 InstitutionsDelirium detection by a novel bispectral electroencephalography device in general hospitalSymptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohortGenome-wide DNA methylation investigation of glucocorticoid exposure within buccal samples
P50
Q33666335-0AC05949-796C-413A-A560-963812AE9922Q33951532-4BE1E92F-701E-4AAC-84A4-13AFBACF3681Q34293851-0AC4599F-E5A1-4160-B848-49DA47652C5BQ37711609-1ED622CA-320D-4D74-9BE0-D985C0D44649Q37851920-9DD86CA2-AF9F-4F02-95D5-5412FBC09BBAQ37852310-763A5C6E-D9E7-4003-A715-6BABE40C3406Q37981923-17F081A6-5943-4E81-8113-F7D716561ADDQ38069321-37A757C8-8BB7-4717-A282-8635FD363C40Q38113879-84B9B0D4-6D39-4919-8522-5C2C210F64D5Q38120361-D6D85827-3FB5-468E-9D88-EC0A8459108DQ38168407-F70208D4-4BF5-4743-AA9F-66D75C69E20BQ38239777-1EEC98DC-3136-4E38-904D-7F74FBF4FEA9Q38246508-48AD9C0B-D1C4-4CE4-B93F-49B49BA85256Q39291559-CC5C801F-0953-4FF0-AD7C-43167194A44AQ40259459-29E52A10-7805-4B7D-BB76-D7AAD19EA27AQ44597593-DD24C693-0349-4C5F-975A-05D9207CD6C2Q48794010-7B7BF228-DE36-4FC9-B66B-62B268784485Q48907506-3CAC330E-8FD1-48CB-9712-59F25ECAEAECQ57159613-23531B19-96AC-4961-AF7F-29F7B34A3E91Q57817802-5908358E-D8D7-434F-8A19-4E79DE79B42EQ61480053-7EEA3CD3-1E3D-47AD-AE10-684DB1E1F0BFQ61805755-677C927E-3740-431B-9CED-334DBE09AE87Q61813287-F1853600-4DE3-43FC-87C7-4AD13F88C88FQ84591573-6834627E-DCD8-45D1-BA1C-019728A314D3Q88516503-27B25E73-60B6-4F65-B492-ECB3CD32E402Q91674769-34079671-836B-4376-BCED-43AA088739D9Q91721476-CDDFF325-7A57-4C5C-A509-151188F2596AQ92030767-4149B037-13C2-4E0B-AE83-661DA7B7626D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gen Shinozaki
@ast
Gen Shinozaki
@en
Gen Shinozaki
@es
Gen Shinozaki
@nl
Gen Shinozaki
@sl
type
label
Gen Shinozaki
@ast
Gen Shinozaki
@en
Gen Shinozaki
@es
Gen Shinozaki
@nl
Gen Shinozaki
@sl
prefLabel
Gen Shinozaki
@ast
Gen Shinozaki
@en
Gen Shinozaki
@es
Gen Shinozaki
@nl
Gen Shinozaki
@sl
P1053
O-1281-2017
P106
P1153
6508121340
P21
P31
P3829
P496
0000-0001-6129-2789